Stay updated on LN-145 & Durvalumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.

Latest updates to the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no changes to study details, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange Detected- Removed the government funding/operational status banner; the study details, eligibility criteria, and locations remain unchanged.SummaryDifference0.4%

- Check35 days agoChange DetectedNo significant changes detected between the old and new screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check64 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference4%

- Check71 days agoChange DetectedUpdated software version from v3.0.2 to v3.1.0, reflecting a new release without other substantive content changes.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; no substantive changes to core content detected. Removal of 'Back to Top' is a minor UI change.SummaryDifference0.3%

Stay in the know with updates to LN-145 & Durvalumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.